Jazz Pharmaceuticals Welcomes Philip Johnson in the Role of Executive VP and CFO
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announces the appointment of Philip Johnson as Executive Vice President and Chief Financial Officer, effective March 1, 2024. Johnson succeeds Renée Galá, who assumed the role of President and Chief Operating Officer in October 2023. Jazz Pharmaceuticals, headquartered in Dublin, Ireland, operates globally with a...